Advertisement
Organisation › Details
Uniqure N.V. (Nasdaq: QURE)
uniQure is a world leader in the development of human gene based therapies. uniQure product pipeline of gene therapy products in development comprise hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. Using adeno-associated viral (AAV) derived vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design and validate probably the world's first stable and scalable AAV manufacturing platform. This proprietary platform can be applied to a large number of rare (orphan) diseases caused by one faulty gene and allows uniQure to pursue its strategy of focusing on this sector of the industry. uniQure's largest shareholders are Forbion Capital Partners and Gilde Healthcare, two of the leading life sciences venture capital firms in the Netherlands. *
Start | 2014-04-09 renamed before | |
Group | Uniqure (Group) | |
Industry | gene therapy | |
Region | Amsterdam | |
Country | Netherlands | |
Street | 61 Meibergdreef | |
City | 1105 BA Amsterdam | |
Tel | +31-20-566-7394 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
Currency | USD | |
Annual sales | 7,281,000 (revenues, total, consolidated (2019) 2019-12-31) | |
Profit | -124,201,000 (2019-12-31) | |
Cash | 377,793,000 (2019-12-31) | |
* Document for »About Section«: | ||
Record changed: 2024-02-12 |
Advertisement
More documents for Uniqure (Group)
- [1] Uniqure N.V.. (3/29/19). "Press Release: Uniqure to Participate in Multiple Upcoming Industry Conferences". Lexington, MA & Amsterdam....
- [2] Uniqure N.V.. (6/13/18). "Press Release: Uniqure Announces New Appointments to its Board of Directors". Lexington, MA & Amsterdam....
- [3] Uniqure N.V.. (10/18/17). "Press Release: Uniqure Presents New Preclinical Data on AMT-130 in Huntington's Disease at the ESGCT 25th Anniversary Congress in Berlin". Lexington, MA & Amsterdam....
- [4] Uniqure N.V.. (5/1/17). "Press Release: Uniqure Announces Company Presentations at Upcoming May Conferences". Lexington, MA & Amsterdam....
- [5] Uniqure N.V.. (2/6/17). "Press Release: Uniqure Announces Presentations at Upcoming February Conferences". Lexington, MA & Amsterdam....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top